Related Experiment Videos

Juvenile idiopathic arthritis: classification, clinical presentation and current treatments

Gunther E Dannecker1, Pierre Quartier

  • 1Department of Pediatric Rheumatology, Olgahospital, Klinikum Stuttgart, Stuttgart, Germany. g.dannecker@klinikum-stuttgart.de

Hormone Research
|November 27, 2009
PubMed

Insights

Juvenile idiopathic arthritis (JIA) is a complex condition with varied symptoms, affecting children under 16. While treatments have improved, a cure remains elusive, focusing on joint function and development.

Area of Science:

  • Pediatric Rheumatology
  • Immunology

Background:

  • Juvenile idiopathic arthritis (JIA) encompasses diverse arthritic conditions with onset before age 16.
  • Etiology is unknown, involving genetic and environmental factors.
  • Improved pharmacologic treatments, including biologics, have enhanced patient prognosis.

Purpose of the Study:

  • To review JIA classification and clinical manifestations.
  • To provide an overview of current pharmacotherapies for JIA subgroups.

Main Methods:

  • Literature review on JIA classification.
  • Summary of clinical presentations across JIA subgroups.
  • Analysis of pharmacologic treatment options for JIA.

Main Results:

  • JIA presents heterogeneously with distinct clinical signs and symptoms per subgroup.
  • Pharmacologic advancements, particularly biologics, have improved JIA management.
  • No current treatment offers a cure for JIA.

Conclusions:

  • JIA treatment requires a multidisciplinary pediatric rheumatology team for optimal care.
  • Therapeutic goals include preserving joint function and supporting normal childhood development.
  • While a cure is not yet available, effective management strategies are crucial.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...